Samsara BioCapital as of June 30, 2026
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 24 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 31.2 | $379M | 6.9M | 55.00 | |
| Alumis (ALMS) | 14.7 | $179M | 6.3M | 28.14 | |
| Mineralys Therapeutics (MLYS) | 13.0 | $158M | 5.9M | 26.98 | |
| Septerna (SEPN) | 8.7 | $106M | 3.1M | 33.49 | |
| Alamar Biosciences Common Stock | 5.5 | $67M | 2.5M | 27.09 | |
| Neurogene (NGNE) | 4.4 | $54M | 1.7M | 31.45 | |
| Kalaris Therapeutics (KLRS) | 4.3 | $52M | 13M | 4.07 | |
| Spyglass Pharma Com Shs (SGP) | 3.9 | $47M | 2.1M | 22.26 | |
| Sutro Biopharma Com Shs (STRO) | 2.9 | $35M | 1.1M | 33.20 | |
| Inventiva Sa Ads (IVA) | 2.0 | $24M | 6.3M | 3.78 | |
| Jade Biosciences Com New (JBIO) | 1.3 | $16M | 736k | 22.22 | |
| Parabilis Medicines | 1.3 | $15M | 556k | 27.37 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.9 | $11M | 299k | 37.65 | |
| Aquestive Therapeutics (AQST) | 0.9 | $10M | 2.5M | 4.16 | |
| Nkarta (NKTX) | 0.8 | $9.9M | 3.5M | 2.83 | |
| Artiva Biotherapeutics (ARTV) | 0.8 | $9.3M | 955k | 9.70 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.6 | $7.9M | 10M | 0.76 | |
| Agomab Therapeutics Nv Sponsored Ads (AGMB) | 0.6 | $7.8M | 600k | 12.98 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.6 | $7.3M | 55k | 133.26 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.5 | $6.5M | 1.4M | 4.67 | |
| Eloxx Pharmaceuticals Com New | 0.5 | $5.6M | 400k | 13.88 | |
| Coherus Biosciences (CHRS) | 0.4 | $4.8M | 3.4M | 1.40 | |
| Upstream Bio (UPB) | 0.2 | $2.4M | 354k | 6.92 | |
| Gossamer Bio (GOSS) | 0.1 | $1.2M | 7.2M | 0.16 |
